{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:18:25Z","timestamp":1777861105620,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13015-0","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:01:21Z","timestamp":1774263681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of Voriconazole-induced periostitis in a tertiary medical center: a single-center retrospective analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Boris","family":"Sokolovski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitai","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Bercovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bar","family":"Rinott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Puchkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Militianu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"13015_CR1","doi-asserted-by":"crossref","unstructured":"Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB, Voriconazole. Clin Ther. 2003;25(5):1321\u20131381, ISSN 0149\u20132918.","DOI":"10.1016\/S0149-2918(03)80126-1"},{"key":"13015_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-0691.2012.03772.x","volume":"18","author":"Y Hicheri","year":"2012","unstructured":"Hicheri Y, Cook G, Cordonnier C. Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect. 2012;18:1\u201315.\u200f","journal-title":"Clin Microbiol Infect"},{"key":"13015_CR3","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30.11","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transpl. 2016;30.11:1377\u201386.\u200f","journal-title":"Clin Transpl"},{"key":"13015_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","volume":"79.8","author":"LL Benitez","year":"2019","unstructured":"Benitez LL, Carver PL. Adverse effects associated with long-term administration of azole antifungal agents. Drugs. 2019;79.8:833\u201353.\u200f","journal-title":"Drugs"},{"key":"13015_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/cid\/ciu513","volume":"59","author":"WJ Moon","year":"2014","unstructured":"Moon WJ, Scheller EL, Suneja A, et al. Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain. Clin Infect Dis. 2014;59:1237\u201345.","journal-title":"Clin Infect Dis"},{"key":"13015_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejim.2004.04.017","volume":"15.6","author":"X Vandemergel","year":"2004","unstructured":"Vandemergel X, Blocklet D, Decaux G. Periostitis and hypertrophic osteoarthropathy: etiologies and bone scan patterns in 115 cases. Eur J Intern Med. 2004;15.6:375\u201380.\u200f","journal-title":"Eur J Intern Med"},{"key":"13015_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1308\/rcsann.2019.0021","volume":"101.5","author":"D Liu","year":"2019","unstructured":"Liu D, et al. Chronic osteomyelitis with proliferative periostitis of the mandibular body: report of a case and review of the literature. Ann R Coll Surg Engl. 2019;101.5:328\u201332.\u200f","journal-title":"Ann R Coll Surg Engl"},{"key":"13015_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00000478-198107000-00002","volume":"5.5","author":"HJ Spjut","year":"1981","unstructured":"Spjut HJ, Dorfman HD. Florid reactive periostitis of the tubular bones of the hands and feet: a benign lesion which may simulate osteosarcoma. Am J Surg Pathol. 1981;5.5:423\u201334.\u200f","journal-title":"Am J Surg Pathol"},{"key":"13015_CR9","doi-asserted-by":"crossref","unstructured":"de Silva P, Evans-Jones G, Wright A, et al. Physiological periostitis; a potential pitfall archives of disease in childhood. 2003;88:1124\u201325.","DOI":"10.1136\/adc.88.12.1124"},{"key":"13015_CR10","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1111\/j.1600-6143.2009.02837.x","volume":"9","author":"TF Wang","year":"2009","unstructured":"Wang TF, Wang T, Altman R, et al. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients. Am J Transpl. 2009;9:2845\u201350.","journal-title":"Am J Transpl"},{"key":"13015_CR11","first-page":"10","volume":"7","author":"MD Bucknor","year":"2013","unstructured":"Bucknor MD, Gross AJ, Link TM. Voriconazole induced periostitis in two post-transplant patients. J Radiol Case Rep. 2013;7:10\u201317.","journal-title":"J Radiol Case Rep"},{"key":"13015_CR12","first-page":"2390","volume":"120.12","author":"B Gerber","year":"2012","unstructured":"Gerber B, et al. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood, J Am Soc Hematol. 2012;120.12:2390\u20134.\u200f","journal-title":"Blood, J The Am Soc Hematol"},{"key":"13015_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cid\/ciq188","volume":"52","author":"RA Wermers","year":"2011","unstructured":"Wermers RA, Cooper K, Razonable RR, et al. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011;52:604\u201311.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13015_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2214\/AJR.18.19991","volume":"212","author":"I Tan","year":"2019","unstructured":"Tan I, Lomasney L, Stacy GS, Lazarus M, Mar WA. Spectrum of voriconazole-induced periostitis with review of the differential diagnosis. AJR Am J Roentgenol. 2019, Jan;212(1):157\u201365. https:\/\/doi.org\/10.2214\/AJR.18.19991. Epub 2018 Nov 7. PMID: 30403528.","journal-title":"AJR Am J Roentgenol"},{"key":"13015_CR15","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1128\/AAC.00872-15","volume":"59","author":"KC Allen","year":"2015","unstructured":"Allen KC, Sanchez CJ Jr, Niece KL, Wenke JC, Akers KS. Voriconazole enhances the osteogenic activity of human osteoblasts in vitro through a fluoride-independent mechanism. Antimicrob Agents Chemother. 2015;59:7205\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"13015_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5500\/wjt.v11.i9.356","volume":"11","author":"AJ Guarascio","year":"2021","unstructured":"Guarascio AJ, Bhanot N, Min Z. Voriconazole-associated periostitis: pathophysiology, risk factors, clinical manifestations, diagnosis, and management. World J Transpl. 2021, Sep, 18;11(9):356\u201371. https:\/\/doi.org\/10.5500\/wjt.v11.i9.356. PMID: 34631468; PMCID: PMC8465512.","journal-title":"World J Transpl"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13015-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:54:14Z","timestamp":1777517654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13015"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13015-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the Rambam Healthcare Campus Institutional Review Board approved this retrospective database study. Approval was obtained from the local ethics committee (0614-22D-RMB)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for the publication of this article in BMC Infectious Diseases. We confirm that the content is original, has not been published elsewhere, and does not infringe upon any third-party rights. We also acknowledge that once published, the article may be available publicly in print and online formats as per the journal\u2019s policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"862"}}